NeuroPace, Inc. (NPCE)
8.22
+0.25
(+3.14%)
USD |
NASDAQ |
Nov 17, 16:00
8.35
+0.13
(+1.58%)
After-Hours: 20:00
NeuroPace EPS Diluted (Quarterly) : -0.096 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.096 |
| June 30, 2026 | -0.1818 |
| March 31, 2026 | -0.1984 |
| December 31, 2025 | -0.0817 |
| September 30, 2025 | -0.1055 |
| June 30, 2025 | -0.2632 |
| March 31, 2025 | -0.2093 |
| December 31, 2024 | -0.1755 |
| September 30, 2024 | -0.1852 |
| June 30, 2024 | -0.2604 |
| March 31, 2024 | -0.3155 |
| December 31, 2023 | -0.2314 |
| September 30, 2023 | -0.2789 |
| June 30, 2023 | -0.3582 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.4134 |
| December 31, 2022 | -0.4488 |
| September 30, 2022 | -0.4766 |
| June 30, 2022 | -0.5179 |
| March 31, 2022 | -0.4715 |
| December 31, 2021 | -0.4373 |
| September 30, 2021 | -0.3325 |
| June 30, 2021 | -0.3496 |
| March 31, 2021 | -0.3627 |
| December 31, 2020 | -0.1938 |
| September 30, 2020 | -0.1732 |
| June 30, 2020 | -0.369 |
| March 31, 2020 | -0.2829 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | -0.1017 |
| Accuray, Inc. | 2.911 |
| Orthofix Medical, Inc. | -0.1475 |
| ResMed, Inc. | 2.918 |
| Rockwell Medical, Inc. | -0.5851 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.298M |
| Revenue (Quarterly) | 23.10M |
| Total Expenses (Quarterly) | 26.40M |
| Enterprise Value | 294.73M |
| Gross Profit Margin (Quarterly) | 84.28% |
| Profit Margin (Quarterly) | -14.27% |
| Earnings Yield | -6.79% |
| Normalized Earnings Yield | -6.695 |